The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthern 2 Vct Regulatory News (NTV)

Share Price Information for Northern 2 Vct (NTV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.50
Bid: 53.00
Ask: 56.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.66%)
Open: 54.50
High: 54.50
Low: 54.50
Prev. Close: 54.50
NTV Live PriceLast checked at -
Northern 2 VCT is an Investment Trust

To invest mainly in unquoted venture capital holdings and aims to provide high long-term tax-free returns to shareholders through a combination of dividend yield and capital growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value

28 Jul 2023 15:30

Net Asset Value

28 July 2023

NORTHERN 2 VCT PLC

UNAUDITED NET ASSET VALUE AS AT 30 JUNE 2023

Northern 2 VCT PLC (“the Company”) is a Venture Capital Trust (“VCT”) launched in 1999 and managed by Mercia Fund Management Limited. The Company’s objective is to provide long-term tax-free returns to investors through a combination of dividend yield and capital growth, by investing in a portfolio of investments mainly comprising unquoted venture capital holdings. In order to maintain approval by HM Revenue & Customs as a VCT, the Company is required to comply on a continuing basis with the provisions of Section 274 of the Income Tax Act 2007.

The unaudited net asset value per ordinary share as at 30 June 2023 was 59.0 pence (31 March 2023: 59.0 pence).

For the purposes of calculating the net asset value per share, quoted investments are carried at bid price as at 30 June 2023 and unquoted investments are carried at fair value as at 30 June 2023 as determined by the directors.

New Investments:During the three months ended 30 June 2023 one new venture capital investment was completed.

Name of company Business activity Amount invested£ million
Camena Bioscience LtdProvider of synthetic DNA1.7

In addition to the new investment above £1.0 million was invested in three existing portfolio companies during the quarter.

Realisations:During the three months ended 30 June 2023 two venture capital investments were realised.

Name of company Sale proceeds Original cost Carrying value at 31 March 2023
 £ million£million£ million
Evotix Ltd11.52.511.5
Adept Technology Group plc (AIM listed)0.30.20.3

The number of ordinary shares in issue at 30 June 2023 was 195,930,908. During the three months ended 30 June 2023 10,290,184 shares were allotted pursuant to the Company’s 2022/23 public share offer.

Enquiries:

Sarah Williams / James Sly, Mercia Fund Management Ltd – 0330 223 1430Website: www.mercia.co.uk/vcts

The contents of the Mercia Asset Management PLC website and the contents of any website accessible from hyperlinks on the Mercia Asset Management PLC website (or any other website), are not incorporated into, nor forms part of, this announcement.

Date   Source Headline
4th Apr 20052:58 pmRNSTransaction in Own Shares
1st Apr 20058:53 amRNSFinal Results
26th Jan 200510:41 amRNSTransaction in Own Shares
25th Jan 20059:01 amRNSTransaction in Own Shares
20th Jan 20059:06 amRNSTransaction in Own Shares
14th Jan 20054:28 pmRNSTransaction in Own Shares
14th Jan 20052:49 pmRNSTransaction in Own Shares
10th Jan 20052:34 pmRNSTransaction in Own Shares
5th Jan 20052:12 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.